Faculty profile

Erik Yeo

Back to faculty

Associate ProfessorDepartment of MedicineUniversity of Toronto

Erik Yeo

Associate Professor

Department of Medicine

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
2 publications in the last five years, latest in 2026.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

2,452

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

A Multicenter Prospective Cohort Study on the Use of Weight‐Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer‐Associated Venous Thromboembolism—The WAVe Study
American Journal of Hematology · 2026
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study.
ACP journal club · 2022
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial
The BMJ · 2021

All 10 publications

Latest funding

Flow cytometric immunoassay for assessment of material induced blood activation under physiological shear rates
NSERC · 1994 · Co-investigator
$176,000

All 1 grants and awards

10 publications.

A Multicenter Prospective Cohort Study on the Use of Weight‐Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer‐Associated Venous Thromboembolism—The WAVe Study

Wang T, Yeo E, Gross PL, Séguin C, Wu C, Shivakumar S, Mallick R, Delluc A, D'Astous J, Kimpton M

American Journal of Hematology2026Open Access

DOI: 10.1002/ajh.70127

Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study.

Le Gal G, Kovacs MJ, Bertoletti L, Couturaud F, Dennie C, Hirsch AM, Huisman MV, Klok FA, Kraaijpoel N, Mallick R

ACP journal club202284 citationsOpen Access

DOI: 10.7326/m21-2981

Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial

Kovacs MJ, Wells PS, Anderson DR, Lazo-Langner A, Kearon C, Bates SM, Blostein M, Kahn SR, Schulman S, Sabri E

The BMJ2021114 citationsOpen Access

DOI: 10.1136/bmj.n1205 PMID: W3172115124

Peak plasma rivaroxaban levels in patients weighing 120 kg or greater

Abdulrehman J, Selby R, Joundi RA, Yeo E

Thrombosis Research20212 citationsSenior author

DOI: 10.1016/j.thromres.2021.02.013

Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant

Douketis JD, Spyropoulos AC, Duncan J, Carrier M, Le Gal G, Tafur AJ, Vanassche T, Verhamme P, Shivakumar S, Gross PL

JAMA Internal Medicine2019519 citationsOpen Access

DOI: 10.1001/jamainternmed.2019.2431 PMID: W2964373888

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Grosso MA, Kakkar AK, Mercuri MF, Meyer G, Segers A, Shi M, Zhang G, Raskob GE, van Es N, Verhamme P

New England Journal of Medicine20181,607 citationsOpen Access

DOI: 10.1056/nejmoa1711948

Erratum to: The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant who Need an Elective Surgery or Procedure: Design and Rationale

Douketis JD, Spyropoulos AC, Anderson JM, Arnold DM, Bates SM, Blostein M, Carrier M, Caprini JA, Clark NP, Coppens M

Thrombosis and Haemostasis20182 citationsOpen Access

DOI: 10.1055/s-0038-1668582

The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale

Douketis JD, Spyropoulos AC, Anderson JM, Arnold DM, Bates SM, Blostein M, Carrier M, Caprini JA, Clark NP, Coppens M

Thrombosis and Haemostasis201788 citationsOpen Access

DOI: 10.1160/th17-08-0553 PMID: W2773460839

Tibial bypass salvage with eptifibatide in a patient with thrombocythemia.

Byrne J, Greco E, Yeo E, McCluskey S, Lindsay T

Journal of vascular surgery cases2015Open Access

DOI: 10.1016/j.jvsc.2015.08.004 PMID: 31724642

A triple-blinded randomized trial comparing the hemostatic effects of large-dose 10% hydroxyethyl starch 264/0.45 versus 5% albumin during major reconstructive surgery.

Arellano R, Gan BS, Salpeter MJ, Yeo E, McCluskey S, Pinto R, Irish J, Ross DC, Doyle DJ, Parkin J, Brown D, Rotstein L, Witterick I, Matthews W, Yoo J, Neligan PC, Gullane P, Lampe H

Anesthesia and analgesia200536 citations

DOI: 10.1213/01.ane.0000152008.04333.53 PMID: 15920225

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Erik Yeo

Research

Latest papers

Latest funding

A Multicenter Prospective Cohort Study on the Use of Weight‐Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer‐Associated Venous Thromboembolism—The WAVe Study

Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study.

Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial

Peak plasma rivaroxaban levels in patients weighing 120 kg or greater

Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Erratum to: The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant who Need an Elective Surgery or Procedure: Design and Rationale

The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale

Tibial bypass salvage with eptifibatide in a patient with thrombocythemia.

A triple-blinded randomized trial comparing the hemostatic effects of large-dose 10% hydroxyethyl starch 264/0.45 versus 5% albumin during major reconstructive surgery.

Flow cytometric immunoassay for assessment of material induced blood activation under physiological shear rates

Frequent collaborators

Marc Carrier

Sudeep Shivakumar

Sam Schulman

Cynthia Wu

Grégoire Le Gal

Peter Lawrence Gross

Shannon Bates

Donald Arnold

Na Li

Frederick Spencer

James Demetrios Douketis

Jeannie Callum

Stephen Kowalski

Stuart McCluskey

David Anderson

Marc Rodger

Susan Kahn

Aurelien Delluc

Summer Syed

Tzu-Fei Wang

Alejandro Lazo-Langner

Elisa Greco

Lorne Rotstein

Thomas Lindsay

Dale Brown